Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 190

1.

Cost-effectiveness analysis of universal childhood hepatitis A vaccination in Brazil: regional analyses according to the endemic context.

Sartori AM, de Soárez PC, Novaes HM, Amaku M, de Azevedo RS, Moreira RC, Pereira LM, Ximenes RA, Martelli CM.

Vaccine. 2012 Dec 14;30(52):7489-97. doi: 10.1016/j.vaccine.2012.10.056.

2.

Regional variation in the cost effectiveness of childhood hepatitis A immunization.

Jacobs RJ, Greenberg DP, Koff RS, Saab S, Meyerhoff AS.

Pediatr Infect Dis J. 2003 Oct;22(10):904-14.

PMID:
14551492
3.

Universal vaccination of children against hepatitis A in Chile: a cost-effectiveness study.

Quezada A, Baron-Papillon F, Coudeville L, Maggi L.

Rev Panam Salud Publica. 2008 May;23(5):303-12.

PMID:
18510790
4.

Hepatitis A: the costs and benefits of the disease prevention by vaccine, Paraná, Brazil.

Zahdi MR, Maluf I Jr, Maluf EM.

Braz J Infect Dis. 2009 Aug;13(4):257-61.

5.

Public Health Impact and Cost-Effectiveness of Hepatitis A Vaccination in the United States: A Disease Transmission Dynamic Modeling Approach.

Dhankhar P, Nwankwo C, Pillsbury M, Lauschke A, Goveia MG, Acosta CJ, Elbasha EH.

Value Health. 2015 Jun;18(4):358-67. doi: 10.1016/j.jval.2015.02.004.

6.

[Cost-utility analysis on universal childhood hepatitis A vaccination in regions with different anti-HAV prevalence rates of China].

Pan XJ, Feng YM, Zhuang GH.

Zhonghua Liu Xing Bing Xue Za Zhi. 2012 Aug;33(8):862-6. Chinese.

PMID:
22967346
7.

Cost-effectiveness of childhood hepatitis A vaccination in Argentina: a second dose is warranted.

Ellis A, Rüttimann RW, Jacobs RJ, Meyerhoff AS, Innis BL.

Rev Panam Salud Publica. 2007 Jun;21(6):345-56.

PMID:
17761046
8.

Cost-utility of universal hepatitis A vaccination in Canada.

Bauch CT, Anonychuk AM, Pham BZ, Gilca V, Duval B, Krahn MD.

Vaccine. 2007 Dec 12;25(51):8536-48.

PMID:
17996339
9.

Cost-effectiveness analysis of a universal infant immunization program with meningococcal C conjugate vaccine in Brazil.

de Soarez PC, Sartori AM, de Andrade Lagoa Nóbrega L, Itria A, Novaes HM.

Value Health. 2011 Dec;14(8):1019-27. doi: 10.1016/j.jval.2011.05.045.

10.

A cost-effectiveness analysis of universal childhood hepatitis A vaccination in China.

Zhuang GH, Pan XJ, Wang XL.

Vaccine. 2008 Aug 18;26(35):4608-16. doi: 10.1016/j.vaccine.2008.05.086.

PMID:
18597903
11.

Cost-effectiveness of universal childhood hepatitis A vaccination in Chile.

Valenzuela MT, Jacobs RJ, Arteaga O, Navarrete MS, Meyerhoff AS, Innis BL.

Vaccine. 2005 Jul 14;23(32):4110-9.

PMID:
15964479
12.

Cost-effectiveness of routine childhood vaccination for hepatitis A in the United States.

Rein DB, Hicks KA, Wirth KE, Billah K, Finelli L, Fiore AE, Hoerger TJ, Bell BP, Armstrong GL.

Pediatrics. 2007 Jan;119(1):e12-21.

PMID:
17200237
14.

Cost-effectiveness of hepatitis A vaccination in Indonesia.

Suwantika AA, Beutels P, Postma MJ.

Hum Vaccin Immunother. 2014;10(8):2342-9. doi: 10.4161/hv.29353.

15.

The cost-effectiveness of universal vaccination of children against hepatitis A in Argentina: results of a dynamic health-economic analysis.

Lopez E, Debbag R, Coudeville L, Baron-Papillon F, Armoni J.

J Gastroenterol. 2007 Feb;42(2):152-60.

PMID:
17351805
16.

Cost-benefit analysis of hepatitis a vaccination in Thailand.

Teppakdee A, Tangwitoon A, Khemasuwan D, Tangdhanakanond K, Suramaethakul N, Sriratanaban J, Poovorawan Y.

Southeast Asian J Trop Med Public Health. 2002 Mar;33(1):118-27.

PMID:
12118439
17.

Assessing potential introduction of universal or targeted hepatitis A vaccination in the Netherlands.

Suijkerbuijk AW, Lugnér AK, van Pelt W, Wallinga J, Verhoef LP, de Melker HE, de Wit GA.

Vaccine. 2012 Jul 27;30(35):5199-205. doi: 10.1016/j.vaccine.2012.06.014.

PMID:
22721900
18.

Pharmaco-economic evaluation of targeted hepatitis A vaccination for children of ethnic minorities in Amsterdam (The Netherlands).

Postma MJ, Bos JM, Beutels P, Schilthuis H, van den Hoek JA.

Vaccine. 2004 May 7;22(15-16):1862-7.

PMID:
15121296
19.

Economic evaluations of hepatitis A vaccination in middle-income countries.

Suwantika AA, Yegenoglu S, Riewpaiboon A, Tu HA, Postma MJ.

Expert Rev Vaccines. 2013 Dec;12(12):1479-94. doi: 10.1586/14760584.2013.851008. Review.

PMID:
24168129
20.

The cost-effectiveness of vaccinating chronic hepatitis C patients against hepatitis A.

Jacobs RJ, Koff RS, Meyerhoff AS.

Am J Gastroenterol. 2002 Feb;97(2):427-34.

PMID:
11866283
Items per page

Supplemental Content

Support Center